All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

In vitro activity of salicylamide derivatives against vancomycin-resistant enterococci

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216275%3A25310%2F18%3A39913065" target="_blank" >RIV/00216275:25310/18:39913065 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11160/18:10382485 RIV/62157124:16170/18:43877055 RIV/62157124:16370/18:43877055

  • Result on the web

    <a href="https://www.sciencedirect.com/science/article/pii/S0960894X18303986?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S0960894X18303986?via%3Dihub</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.bmcl.2018.05.011" target="_blank" >10.1016/j.bmcl.2018.05.011</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    In vitro activity of salicylamide derivatives against vancomycin-resistant enterococci

  • Original language description

    A series of 13 salicylamide derivatives was assessed for antibacterial activity against three isolates of vancomycin-resistant Enterococcus faecalis (VRE) and Enterococcus faecalis ATCC 29212 as a quality standard. The minimum inhibitory concentration was determined by the broth microdilution method with subsequent subcultivation of aliquots to assess minimum bactericidal concentration. The growth kinetics was established by the time-kill assay. Ampicillin, ciprofloxacin, tetracycline and vancomycin were used as the reference antibacterial drugs. Three of the investigated compounds showed strong bacteriostatic activity against VRE (0.199-25 mu M) comparable to or more potent than ampicillin and ciprofloxacin. In addition, these compounds were tested for synergistic effect with vancomycin, ciprofloxacin and tetracycline, while 5-chloro-2-hydroxy-N-[4-(trifluoromethyl)phenyl]benzamide showed the highest potency as well as synergistic activity with vancomycin against VRE 368. Screening of the cytotoxicity of the most effective compounds was performed using human monocytic leukemia THP-1 cells, and based on LD50 values, it can be stated that the compounds have insignificant toxicity against human cells.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30104 - Pharmacology and pharmacy

Result continuities

  • Project

    <a href="/en/project/GA18-03847S" target="_blank" >GA18-03847S: Pseudopeptide proteasome inhibitors</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2018

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Bioorganic &amp; Medicinal Chemistry Letters

  • ISSN

    0960-894X

  • e-ISSN

  • Volume of the periodical

    28

  • Issue of the periodical within the volume

    12

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    5

  • Pages from-to

    2184-2188

  • UT code for WoS article

    000434468000013

  • EID of the result in the Scopus database

    2-s2.0-85047082986